{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-029381","form_type":"8-K","ticker":"VXRT","cik":"0000072444","company_name":"Vaxart, Inc.","filed_at":"2022-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.371440+00:00","generated_at":"2026-06-21T02:56:34.182319+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Vaxart appoints Phillip Lee as CFO; interim CFO Fuad Ahmad steps down","bullets":["Phillip Lee appointed CFO, Principal Accounting Officer, and Principal Financial Officer effective Dec 15, 2022.","Lee previously CFO at Clover Biopharmaceuticals; brings ~15 years biotech finance experience.","Lee receives $420K base salary, 40% target bonus, option for 412,500 shares, and 68,750 RSUs.","Fuad Ahmad ceased as Interim CFO on same date.","Press release issued Dec 19, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-029381","json":"https://secwatch.observer/filing/0001437749-22-029381.json","markdown":"https://secwatch.observer/filing/0001437749-22-029381.md","text":"https://secwatch.observer/filing/0001437749-22-029381.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/0001437749-22-029381-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/vxrt20221219_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T02:56:34.182319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"523b622358","claim":"Phillip E. Lee was appointed as Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer at Vaxart, Inc..","evidence_excerpt":"On December 15, 2022 (the “ Start Date ”), Vaxart, Inc. (the “ Company ”) appointed Phillip E. Lee as the Company’s Chief Financial Officer and as the Company’s Principal Accounting Officer and Principal Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/0001437749-22-029381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a7173789a3","claim":"Fuad Ahmad departed as Interim Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer at Vaxart, Inc..","evidence_excerpt":"As of December 15, 2022, Fuad Ahmad ceased to serve as the Company’s Interim Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/72444/000143774922029381/0001437749-22-029381-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased"},{"label":"Role","value":"Interim Chief Financial Officer, Principal Accounting Officer, and Principal Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}